Heidelberg Pharma AG (FRA:HPHA)
2.810
0.00 (0.00%)
At close: Nov 28, 2025
Heidelberg Pharma AG Employees
Heidelberg Pharma AG had 105 employees as of November 30, 2024. The number of employees increased by 10 or 10.53% compared to the previous year.
Employees
105
Change (1Y)
10
Growth (1Y)
10.53%
Revenue / Employee
€26,644
Profits / Employee
€229,629
Market Cap
134.73M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Nov 30, 2024 | 105 | 10 | 10.53% |
| Nov 30, 2023 | 95 | -7 | -6.86% |
| Nov 30, 2022 | 102 | 13 | 14.61% |
| Nov 30, 2021 | 89 | 11 | 14.10% |
| Nov 30, 2020 | 78 | 8 | 11.43% |
| Nov 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Nov 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Siemens Aktiengesellschaft | 318,000 |
| Deutsche Telekom AG | 198,194 |
| Mercedes-Benz Group AG | 175,264 |
| Bayerische Motoren Werke Aktiengesellschaft | 159,104 |
| Allianz SE | 156,626 |
| SAP SE | 109,121 |
| Siemens Energy AG | 103,000 |
| Deutsche Bank Aktiengesellschaft | 89,753 |
Heidelberg Pharma AG News
- 26 days ago - EQS-News: Heidelberg Pharma’s Lead ATAC Candidate HDP-101 Shows Progress in Phase I/IIa Trial in Multiple Myeloma - Wallstreet:Online
- 4 weeks ago - EQS-News: Heidelberg Pharma to Present New Clinical Data of Lead ADC Candidate HDP-101 at the World ADC Congress 2025 and to Host Webinar - Wallstreet:Online
- 7 weeks ago - EQS-NVR: Heidelberg Pharma AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution - Wallstreet:Online
- 7 weeks ago - Heidelberg Pharma's Bold Moves in 2025's First 9 Months - Wallstreet:Online
- 7 weeks ago - EQS-News: Heidelberg Pharma Reports on the First Nine Months of Financial Year 2025 - Wallstreet:Online
- 2 months ago - Heidelberg Pharma AG Boosts Outlook: Exciting New Guidance Revealed! - Wallstreet:Online
- 2 months ago - EQS-Adhoc: Heidelberg Pharma AG Announces Updated Guidance - Wallstreet:Online
- 2 months ago - EQS-News: Heidelberg Pharma Advances to Cohort 9 in Phase I/IIa Trial of Lead ATAC Candidate HDP-101 in Multiple Myeloma - Wallstreet:Online